Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
humatin
Synonyms :
Cetenulin, monomycin A, paromomycin I
Class :
Anti-parasitic, Aminoglycoside
Brand Name :
humatin
Synonyms :
Cetenulin, monomycin A, paromomycin I
Class :
Anti-parasitic, Aminoglycoside
Dosage Forms & StrengthsÂ
capsuleÂ
250mgÂ
25 - 35
mg/kg/day
Capsule
Orally 
every 6 hours
5 - 10
days
4
g
Capsule
Orally 
every day
5 - 6
days
20 - 30
mg/kg
Capsule
Orally 
every 8 hrs
Dosage Forms & StrengthsÂ
capsuleÂ
250mgÂ
25-35mg/kg/day every 8 hours orally for seven days
Or
750mg/m2/day every 6 hours orally for five days
25 - 35
mg/kg
Orally 
every 8 hrs
5 - 10
days
25 - 35
mg/kg
Orally 
every 8 hrs
5 - 10
days
25 - 35
mg/kg
Orally 
every 8 hrs
5 - 10
days
20 - 30
mg/kg
Capsule
Orally 
every 8 hours
may decrease the therapeutic effect of antibiotics
may increase the nephrotoxic effect of aminoglycosides
may decrease the therapeutic effect of antibiotics
may increase the toxic effect of aminoglycosides
may decrease the therapeutic effect of antibiotics
may increase the nephrotoxic effect
may increase the nephrotoxic effect
may increase the neuromuscular-blocking effect
may increase the nephrotoxic effect
may diminish the serum concentration of pencillins
may diminish the serum concentration of pencillins
may diminish the serum concentration of pencillins
may diminish the serum concentration of pencillins
may diminish the serum concentration of pencillins
may increase the nephrotoxic effect
may increase the hypo calcaemic effect
may increase the hypo calcaemic effect
may increase the hypo calcaemic effect
may increase the hypo calcaemic effect
may increase the hypo calcaemic effect
may increase the neuromuscular-blocking effect
may increase the nephrotoxic effect
may increase the nephrotoxic effect
may increase the nephrotoxic effect
may increase the nephrotoxic effect
may increase the nephrotoxic effect
may increase the ototoxic effect
may increase the therapeutic effect of antibiotics
may increase the therapeutic effect of antibiotics
may increase the therapeutic effect of antibiotics
may increase the therapeutic effect of antibiotics
may increase the therapeutic effect of antibiotics
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
it interacts with meclizine through an unspecified mechanism of interaction
Frequency defined:Â Â
1-10%Â
Abdominal crampsÂ
VomitingÂ
DiarrheaÂ
NauseaÂ
HeartburnÂ
<1%Â
VertigoÂ
RashÂ
SteatorrheaÂ
EosinophiliaÂ
HeadacheÂ
ExanthemaÂ
PruritisÂ
Secondary enterocolitisÂ
OtotoxicityÂ
Pregnancy consideration:Â Â
US FDA pregnancy category: CÂ
Lactation: Excretion of the drug in human breast milk is unknownÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Patient information leafletÂ
Generic Name: paromomycinÂ
Pronounced: [ PAR-oh-moe-MYE-sin]Â
Why do we use paromomycin?Â
It is used in the treatment of acute and chronic intestinal amebiasis and acts as a supplement in hepatic comaÂ
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
